Enable Accessibility Enable Accessibility

Director/PDMR Share Dealings

September 30, 2015

September 30, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Ordinary Shares (“Shares”) and American Depositary Shares (“ADSs”) of the Company, as set out below, have been acquired today for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from July 1 to September 30, 2015.

 

Type of Security (1)

Number of Shares/ADSs

Dominic Blakemore

Shares

129

Olivier Bohuon

Shares

127

William Burns

Shares

155

Dr. Steven Gillis

ADSs

52

Dr. David Ginsburg

ADSs

45

David Kappler

Shares

151

Susan Kilsby

ADSs

154

Sara Mathew

ADSs

16

Anne Minto

Shares

154

(1) One ADS is equal to three Shares

The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively at £44.98 per Share and $204.1653 per ADS.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary

For further information please contact:

Investor Relations

 

 

Matthew Osborne

mattosborne@shire.com

+1 781 482 9502

Sarah Elton-Farr

seltonfarr@shire.com

+44 1256 894157

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

www.shire.com